Released June 18, 2019 | Galway
en
This summer is expected to be a busy time for Europe's Pharmaceutical & Biotech Industry, as more than 130 projects with a combined worth of more than $2.8 billion are planned to kick off in the next three months. Plant expansions account for more than $1 billion. The three largest projects include an API and dermatologic preparations fucidine production plant expansion; Phase 1 of a grassroot feringa life science research plant, and a cancer research institute addition. Click here for the list of projects and see graph below for project spending by country.
